Hyloris Pharmaceuticals SA Financial Overview
Hyloris Pharmaceuticals SA's market cap is currently €169.68M. The company's EPS TTM is €-0.127; its P/E ratio is -25.94; Hyloris Pharmaceuticals SA is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
